Use of lecithin as a medication for the treatment of psoriasis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 20, 2010
Grant Date -
Jun 26, 2008
app pub date -
Apr 11, 2006
filing date -
Apr 18, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods and compositions for the prevention and treatment of recent and old dermatitis, especially psoriasis, using lecithin or a lecithin-rich extract. According to one embodiment, phospholipids constituting the lecithin are esterified by Omega 3-type polyunsaturated fatty acids, in particular by docosahexaensic acid (DHA) and eicosapentaenoic acid (EPA) or by an alkyl glycerol. The lecithin can be of marine origin, extracted from a marine organisms such as fish, shrimp, krill, zooplankton, algae, and phytoplankton, which are advantageous in that their phospholipids, especially phosphatidylcholine, are naturally esterified by Omega 3 fatty acids, and essentially by DHA and EPA.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully